JCB logo
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Retraction for Bois et al., J. Cell Biol. 170 (6) 903-912.
Published online
doi:10.1083/jcb.20050104020070420r
The Journal of Cell Biology, Vol. 177, No. 3, 563-
The Rockefeller University Press, 0021-9525 $30.00
© Bois et al.
This Article
Right arrow Full Text (PDF, 413K)
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bois, P. R.J.
Right arrow Articles by Grosveldz, G. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bois, P. R.J.
Right arrow Articles by Grosveldz, G. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Retraction

FOXO1a acts as a selective tumor suppressor in alveolar rhabdomyosarcoma



Philippe R.J. Bois, Kamel Izeradjene, Peter J. Houghton, John L. Cleveland, Janet A. Houghton, and Gerard C. Grosveldz

Vol. 170 No. 6, September 12, 2005. Pages 903–912.

The editors of The Journal of Cell Biology have been notified by Dr. Gerard C. Grosveld of St. Jude Children's Research Hospital, Memphis, TN, that he and the other authors of the above article wish to retract the paper.

The authors state:

"Figure 1 of this paper was described as reflecting an experiment that showed that the expression of the FOXO1a protein was downregulated in primary tumor samples of alveolar rhabdomyosarcoma patients. In follow-up experiments, however, we have shown that the lack of FOXO1a expression reported in Figure 1 is not correct. We are now certain that primary alveolar rhabdomyosarcoma cells do express FOXO1a protein.

Given that the lack of FOXO1a protein in primary tumors was the basis for proposing that FOXO1a acts as a tumor suppressor in this childhood tumor, we must retract the paper in its entirety."


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


This Article
Right arrow Full Text (PDF, 413K)
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bois, P. R.J.
Right arrow Articles by Grosveldz, G. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bois, P. R.J.
Right arrow Articles by Grosveldz, G. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents